Written and maintained by CASRAI Editorial Board
Published
On this page
The British Journal of Hematology (officially published under the British spelling British Journal of Haematology, and abbreviated as BJHaem or BJH) is an international peer-reviewed medical journal covering clinical and laboratory hematology. Founded in 1955, the journal serves as the official organ of the British Society for Haematology (BSH) and is published by Wiley-Blackwell. It provides hematologists and laboratory scientists with original research, clinical guidelines, and reviews across benign and malignant hematologic disorders.
Medical Disclaimer: This guide provides editorial, bibliographic, and publishing process information. It does not provide clinical advice or patient treatment protocols.
What it is
The British Journal of Hematology is a core medical periodical indexed by the National Library of Medicine (NLM ID: 0372544; NLM Title Abbreviation: Br J Haematol) with continuous publication since 1955. The journal carries print ISSN 0007-1048 and electronic ISSN 1365-2141 (CODEN: BJHEAL). Operating as an authoritative platform in laboratory and clinical medicine, the journal documents fundamental laboratory findings, diagnostic criteria, and therapeutic trials.
While North American institutions frequently search the American spelling “British Journal of Hematology,” the official masthead retains the British spelling, British Journal of Haematology. Both terms denote the exact same publication. In biomedical practice, the scope of blood sciences connects directly to the principles outlined in our guide on what is hematology, as well as the subspecialty distinctions explored in oncology vs hematology.
Bibliographically, BJHaem operates on a semi-monthly publication schedule, producing 23 issues annually. The journal is indexed in MEDLINE, PubMed, Science Citation Index, Scopus, and Index Medicus. According to Crossref records, the journal maintains over 29,900 registered Digital Object Identifiers (DOIs), with deposits supporting open citations, ORCID attribution, Crossmark update policies, and funding agency tracking.
Who runs it and what it covers
Governance of the journal represents an enduring partnership between an academic professional society and commercial scholarly publishing:
- Sponsoring Society: The journal is owned and directed by the British Society for Haematology (BSH), a registered charity (No 1005735) and company limited by guarantee (No 02645706) located at 100 White Lion Street, London N1 9PF. BSH establishes the strategic editorial vision and commissions official clinical guidelines.
- Publisher: Wiley-Blackwell manages production, hosting on Wiley Online Library, worldwide institutional licensing, and submission workflows.
- Editorial Board: Editorial oversight is led by an academic Editor-in-Chief supported by an international editorial board of clinical hematologists and hematopathologists.
The substantive scope of the journal covers the full spectrum of hematological science, including:
- Malignant Hematology: Leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms.
- Non-Malignant Hematology: Hemoglobinopathies, aplastic anemia, bone marrow failure, and iron metabolism disorders.
- Hemostasis and Thrombosis: Venous thromboembolism, bleeding disorders, hemophilia, platelet biology, and anticoagulation.
- Transfusion Medicine: Blood banking standards, donor safety, hemovigilance, and stem cell transplantation.
- Laboratory Diagnostics: Flow cytometry, molecular genetics, automated cell morphology, and quality control.
- BSH Clinical Guidelines: Evidence-based practice guidelines establishing clinical care pathways across the UK and internationally.
How to search or use it
Researchers, authors, and clinicians interact with the journal through Wiley Online Library (onlinelibrary.wiley.com/journal/13652141) and the BSH membership portal. Navigating the platform involves the following verified steps:
- Locating the Interface: Open the journal homepage on Wiley Online Library. Institutional readers sign in via federated Single Sign-On (Shibboleth/OpenAthens) using the “Institutional Login” option. BSH members access subscriber privileges by signing in through the official BSH website (
b-s-h.org.uk). - Conducting Targeted Searches: Use the search bar beneath the journal masthead. Select “In this journal” to restrict keyword queries to BJHaem’s archive, or search across Wiley’s complete collection. Advanced search filters allow refining by date, author ORCID, or DOI.
- Accessing Early View: Click “Early View” to read peer-reviewed articles published online ahead of scheduled issues. Historical volumes dating to 1955 appear under “All Issues.”
- Retrieving BSH Guidelines: Select the “Guidelines” filter or search “British Society for Haematology Guidelines” to access full-text clinical consensus documents without subscription paywalls.
- Exporting Citations: Within any article, use “Export Citation” to download references for EndNote, BibTeX, or Zotero, linking into citation tracking and journal impact factor metrics.
- Submitting Manuscripts: Prospective authors select “Submit an Article” to enter Wiley’s submission system. Authors upload files, provide data availability statements, declare conflicts of interest, and confirm compliance with BSH ethical declarations.
Note on digital access: Individual journal smartphone apps were decommissioned on January 15, 2024; access is now unified via Wiley Online Library and the BSH portal.
Strengths and limits
Evaluating the British Journal of Hematology highlights several structural advantages and practical limitations:
Key Strengths
- BSH Guideline Authority: BJHaem is the official publisher of British Society for Haematology clinical guidelines, making it a primary reference for clinicians and hospital laboratories.
- Balanced Clinical Focus: BJHaem maintains equal editorial prestige for diagnostic laboratory techniques, morphology, and clinical patient care.
- Rapid Dissemination: Continuous publication through Early View ensures accepted research is citable and indexed in PubMed ahead of formal print issue assignment.
- Flexible Publishing Models: As a hybrid journal, authors can publish under subscription arrangements without author fees, or select gold open access under Creative Commons licenses. Wiley’s transitional agreements (such as UK Jisc) frequently cover open access fees for affiliated researchers.
Editorial and Practical Limits
- Selective Acceptance: High submission volumes result in selective triage for unreferenced preliminary findings or small case series.
- High Open Access APC: For authors whose institutions lack a transformative agreement, the list Article Publication Charge (APC) for Gold Open Access stands at approximately USD $5,190.
- Strict Word Constraints: Original research articles must adhere strictly to length limits (typically 3,000 to 3,500 words) and restrict display items to 6 or 7 combined tables and figures.
Alternatives
When selecting a target journal in hematology, authors frequently compare the British Journal of Hematology with other major international periodicals. The following table compares key peer publications based on primary registry data and publisher specifications:
| Journal Title | Official Sponsoring Society | Publishing House | Publishing Model | Core Editorial Emphasis |
|---|---|---|---|---|
| British Journal of Haematology (BJHaem) | British Society for Haematology (BSH) | Wiley-Blackwell | Hybrid (Subscription or Gold OA; APC ~$5,190) | Broad clinical hematology, diagnostic laboratory medicine, and BSH guidelines |
| Blood | American Society of Hematology (ASH) | Elsevier | Hybrid (Subscription or Gold OA) | High-impact basic, translational, and clinical hematology; flagship journal for ASH; related to Blood impact factor metrics |
| Haematologica | Ferrata Storti Foundation | Ferrata Storti Foundation | Immediate Gold Open Access | European and global clinical, experimental, and molecular hematology |
| The Lancet Haematology | Independent Editorial Board | Elsevier / The Lancet Group | Hybrid (Subscription or Gold OA) | Phase II/III clinical trials, global health policy, and oncology-hematology practice |
| American Journal of Hematology | Independent Editorial Board | Wiley-Blackwell | Hybrid (Subscription or Gold OA) | Clinical hematology, registry studies, and targeted therapeutic outcomes |
For research teams evaluating publishing models, consulting institutional guides on open access publishing helps determine whether grant mandates require immediate repository archiving or funded publisher open access.
FAQ
What is the difference between British Journal of Hematology and British Journal of Haematology?
There is no difference in the underlying entity. British Journal of Haematology is the official formal title registered with the National Library of Medicine (NLM ID: 0372544) and the British Society for Haematology, utilizing British spelling (“ae”). “British Journal of Hematology” is the standard American English spelling widely entered by searchers and indexing systems. Both spellings refer to the identical Wiley-published journal.
Is the British Journal of Haematology an open access journal?
The British Journal of Haematology is a hybrid journal. Authors may choose between traditional subscription publishing (which carries no author fees) and Gold Open Access. Under Gold Open Access, the author or funder pays an Article Publication Charge (APC) of approximately USD $5,190 to make the article immediately available under a Creative Commons license (CC BY or CC BY-NC). Authors affiliated with institutions participating in Wiley transitional agreements (such as UK Jisc) publish open access with fees covered by the agreement.
Where are official British Society for Haematology clinical guidelines published?
Official BSH clinical guidelines and diagnostic recommendations are published directly in the British Journal of Haematology. These guidelines are compiled by multidisciplinary BSH Task Forces, undergo peer review, and are made freely accessible on both the Wiley Online Library journal portal and the official British Society for Haematology website.
How frequently is the British Journal of Haematology published?
The journal publishes 23 issues per year on a semi-monthly schedule, supplemented by special thematic issues and conference abstract supplements. Individual accepted articles appear online continuously in Wiley’s Early View repository prior to formal issue allocation.
Sources
- National Library of Medicine (NLM) Catalog: Record 0372544 for British journal of haematology (NLM Abbreviation: Br J Haematol; ISSN: 0007-1048, 1365-2141). Verified at
https://www.ncbi.nlm.nih.gov/nlmcatalog/0372544(Checked: 2026-11-12). - British Society for Haematology (BSH): Official Journal Governance, Membership Access, and Guideline Information. Verified at
https://b-s-h.org.uk/membership/british-journal-of-haematology(Checked: 2026-11-12). - Crossref Scholarly Database: Journal Record for ISSN 1365-2141 (Wiley-Blackwell DOI deposits, metadata standards, Crossmark policies). Verified at
https://api.crossref.org/journals/1365-2141(Checked: 2026-11-12). - OpenAlex Scholarly Registry: Source Record for British Journal of Haematology (ISSN 1365-2141; publication counts, citation metrics, hybrid publishing status, APC data). Verified at
https://api.openalex.org/sources?filter=issn:1365-2141(Checked: 2026-11-12).







